Table 4. Sensitivity and specificity of nine top mutated genes between tumor DNA and cfDNA of stage IV GC patients.
| TP53 | ARID1A | KMT2C | KMT2D | FAT4 | LRP1B | MACF1 | CDH1 | PLB1 | ||||||||||
| Tumor DNA mutation | Tumor DNA mutation | Tumor DNA mutation | Tumor DNA mutation | Tumor DNA mutation | Tumor DNA mutation | Tumor DNA mutation | Tumor DNA mutation | Tumor DNA mutation | ||||||||||
| Yes | No | Yes | Yes | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | Yes | No | |
| cfDNA mutation | ||||||||||||||||||
| Yes | 3 | 0 | 5 | 0 | 6 | 0 | 8 | 0 | 8 | 0 | 5 | 0 | 4 | 0 | 3 | 0 | 3 | 0 |
| No | 19 | 34 | 15 | 36 | 9 | 41 | 3 | 45 | 1 | 47 | 2 | 49 | 1 | 51 | 1 | 52 | 1 | 52 |
| Sensitivity | 13.6% | 25% | 40% | 72.7% | 88.9% | 71.4% | 80% | 75% | 75% | |||||||||
| Specificity | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | |||||||||
Abbreviations: cfDNA: cell-free DNA; GC: gastric cancer.